Role of Magnetic Resonance Imaging Using Prostate Imaging-Reporting and Data System Version 2 to Predict Clinically Significant Cancer After Radical Prostatectomy in Very Low-Risk or Low-Risk Prostate Cancer
The Korean Journal of Urological Oncology. 2017;15(2):66-71 
Prostate Imaging Reporting and Data System version 2-based predictive model can predict candidates for nerve sparing radical prostatectomy among low-intermediate risk prostate cancer patients
European Urology Open Science. 2020;19:e618
A Risk Model for Detecting Clinically Significant Prostate Cancer Based on Clinical Parameters and the Prostate Imaging Reporting and Data System using Bi-parametric Magnetic Resonance Imaging in a Japanese Cohort.
. 2021;
Prospective validation of prostate imaging reporting and data system version 2 on multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer with pathology after radical prostatectomy as the reference standard
European Urology Supplements. 2018;17(8):179-180
Re: Risk of Clinically Significant Prostate Cancer Associated with Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI
Journal of Urology. 2018;200(1):11-11
Nonvisible tumors on multiparametric magnetic resonance imaging does not predict low-risk prostate cancer
Prostate International. 2015;3(4):127-131
A Prospective Accuracy Study of Prostate Imaging Reporting and Data System Version 2 on Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer With Whole-mount Pathology
Urology. 2019;123:191-197
The Utility of Combined Target and Systematic Prostate Biopsies in the Diagnosis of Clinically Significant Prostate Cancer Using Prostate Imaging Reporting and Data System Version 2 Based on Biparametric Magnetic Resonance Imaging
Current Oncology. 2021;28(2):1294-1301
A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer
BJU International. 2011;108(8b):E164-E170
Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer
Cancer. 2014;120(18):2876-2882